Mirae Asset Global Etfs Holdings Ltd. Artivion, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,711 shares of AORT stock, worth $809,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,711
Previous 20,890
15.22%
Holding current value
$809,392
Previous $649,000
15.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AORT
# of Institutions
224Shares Held
39.8MCall Options Held
23.3KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$138 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.48MShares$114 Million0.13% of portfolio
-
Morgan Stanley New York, NY2.24MShares$102 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.02MShares$92.3 Million0.19% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.84B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...